IGM Biosciences Inc (IGMS)
8.89
-0.88
(-8.96%)
USD |
NASDAQ |
Nov 21, 16:00
8.75
-0.14
(-1.57%)
After-Hours: 20:00
IGM Biosciences Shareholders Equity (Quarterly): 78.95M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 78.95M |
| June 30, 2024 | 122.36M |
| March 31, 2024 | 161.25M |
| December 31, 2023 | 203.23M |
| September 30, 2023 | 253.86M |
| June 30, 2023 | 258.61M |
| March 31, 2023 | 239.43M |
| December 31, 2022 | 287.26M |
| September 30, 2022 | 328.18M |
| June 30, 2022 | 375.41M |
| March 31, 2022 | 204.52M |
| December 31, 2021 | 244.91M |
| Date | Value |
|---|---|
| September 30, 2021 | 285.58M |
| June 30, 2021 | 322.46M |
| March 31, 2021 | 355.61M |
| December 31, 2020 | 381.82M |
| September 30, 2020 | 188.18M |
| June 30, 2020 | 206.95M |
| March 31, 2020 | 224.01M |
| December 31, 2019 | 240.23M |
| September 30, 2019 | 254.62M |
| June 30, 2019 | 81.73M |
| December 31, 2018 | -65.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
78.95M
Minimum
Sep 2024
381.82M
Maximum
Dec 2020
248.14M
Average
242.57M
Median
Shareholders Equity (Quarterly) Benchmarks
| Moderna Inc | 11.93B |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 304.51M |
| Total Liabilities (Quarterly) | 225.56M |
| Current Ratio | 5.223 |